Balchem Corp. (NASDAQ: BCPC) reported Q2 EPS of $0.64, $0.01 better than the analyst estimate of $0.63. Revenue for the quarter came in at $147.08 million versus the consensus estimate of $142.75 million.

Second Quarter 2017 Financial Highlights:

• Record second quarter net sales of $147.1 million in 2017, an increase of 6.0%, compared to the second quarter of 2016.
• Record sales and record second quarter earnings from operations for our Human Nutrition & Health segment, along with record sales and record earnings from operations for our Specialty Products segment, and a significant increase in both sales and earnings from operations for our Industrial Products segment compared to the second quarter 2016.
• Lower sales and earnings from operations for our Animal Nutrition & Health segment, with decreased ruminant volumes and monogastric margin compression.
• Record second quarter net earnings were $16.5 million, an increase of $2.4 million, or 16.9% from the prior year, resulting in earnings per share of $0.51.
• Second quarter adjusted net earnings of $20.5 million decreased $0.6 million or 2.7% from the prior year, resulting in adjusted earnings per share(a) of $0.64.
• Second quarter cash flows from operations were $22.9 million for 2017 compared to $26.6 million for 2016. Free cash flow(a) for the second quarter 2017 was $15.0 million compared to $22.6 million for the second quarter 2016, a decrease of $7.6 million.
• Principal payments made, including accelerated payments, of $13.3 million on long-term debt and the revolving loan.

For earnings history and earnings-related data on Balchem Corp. (BCPC) click here.